NCT00505466

Brief Summary

The goal of this study is to design a means of providing research families, from diverse geographical locations, the chance to receive genetic testing after having been educated by video, and meetings or telephone conversations with a genetic counselor/study professional. This is an investigational study. About 800 people will be offered genetic testing. This study is being performed only at MD Anderson.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
577

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 1999

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 6, 1999

Completed
8.2 years until next milestone

First Submitted

Initial submission to the registry

July 19, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 23, 2007

Completed
14.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2022

Completed
Last Updated

March 4, 2022

Status Verified

March 1, 2022

Enrollment Period

22.8 years

First QC Date

July 19, 2007

Last Update Submit

March 3, 2022

Conditions

Keywords

Human GeneticsGenetic CounselingGenetic Testingp53 MutationGenetics

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Received Pre-test Genetic Counseling

    10 Years

Secondary Outcomes (1)

  • Number of participants completing genetic testing for p53

    Baseline to time of follow-up (2 weeks, 6, and 12 months)

Study Arms (1)

Pre-Test Genetic Counseling + Genetic Sample

Behavioral: Genetic Counseling

Interventions

Genetic counseling conducted in person, by telephone with an M. D. Anderson Genetic Counselor, or with a local Genetic Counselor in conference with the M. D. Anderson Genetic Counselor.

Pre-Test Genetic Counseling + Genetic Sample

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient diagnosed with cancer or a participant with a family member who has had cancer.

You may qualify if:

  • Genetic testing
  • Members of families who have participated in the p53 project through Dr. Strong's lab are eligible, via protocol P90-001. There are at least 145 kindreds including at least 800 participants living who may be at risk of carrying a p53 germline mutation. The participants must provide an informed consent and be 18 years or older. We will include English and non-English speaking participants. For non-English speaking participants to be recruited, the consent documents has been translated into the language of the target population in accordance with the IRB procedures.
  • Parents Attitudes toward testing children at risk for TP53 mutations
  • For the survey portion of this study, we will invite individuals who 1) are already enrolled in the P90-001 study), 2) have been known to carry a germline p53 mutation, and 3) have children who are less than 27 years old. Patients who agree to enroll in the survey portion of the study will be presented with a consent statement and a printed copy of the survey along with a postage-paid envelope which they can return (either by mail or in person) at their convenience.
  • Psychosocial impact of participating in LFS screening
  • Adults who have undergone genetic testing and have a confirmed p53 mutation
  • Adults participating in LFS screening program

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Optional small sample of blood (about 6 tablespoons) for genetic testing for p53 following pre-test genetic counseling.

MeSH Terms

Interventions

Genetic Counseling

Intervention Hierarchy (Ancestors)

Genetic ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Louise C. Strong, MD

    M.D. Anderson Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2007

First Posted

July 23, 2007

Study Start

May 6, 1999

Primary Completion

February 8, 2022

Study Completion

February 8, 2022

Last Updated

March 4, 2022

Record last verified: 2022-03

Locations